The sample included 16 participants with PEO (8 associated with single mtDNA deletion, including 3 KSS; 8 with mutations in POLG), nine with OPMD with mutations in PABPN1, and nine controls without histological or clinical evidence of myopathy. The gene discussed is PABPN1; the disease is myopathy.